Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

ClinicalTrials.gov ID: NCT05877547

Public ClinicalTrials.gov record NCT05877547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults With Precirrhotic Nonalcoholic Steatohepatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn how well efinopegdutide works compared to placebo in people who have non-alcoholic steatohepatitis (NASH). Researchers will also learn about the safety and benefit of efinopegdutide and how well people tolerate the medicine. The main goal of the study is to compare how many people taking efinopegdutide or placebo stop showing evidence of NASH without liver scarring getting worse.

Study identification

NCT ID
NCT05877547
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
381 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 23, 2023 (Actual)
Primary completion
Dec 29, 2025 (Actual)
Completion
Dec 29, 2025 (Actual)
Last update posted
Jan 12, 2026

2023 – 2025

United States locations

U.S. sites
42
U.S. states
14
U.S. cities
39
Facility City State ZIP Site status
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 3 Chandler Arizona 85224 —
The Institute for Liver Health II dba Arizona Clinical Trials - Peoria ( Site 3289) Peoria Arizona 85381 —
The Institute for Liver Health II dba Arizona Liver Health-Tucson ( Site 3218) Tucson Arizona 85712 —
Del Sol Research Management, LLC ( Site 3211) Tucson Arizona 85715 —
Om Research - Apple Valley ( Site 3244) Apple Valley California 92307 —
Om Research LLC ( Site 3245) Camarillo California 93012 —
Velocity Clinical Research, Gardena ( Site 3225) Gardena California 90247 —
Velocity Clinical Research, Huntington Park ( Site 3217) Huntington Park California 90255 —
Velocity Clinical Research, San Diego ( Site 3226) La Mesa California 91942 —
Om Research LLC ( Site 3229) Lancaster California 93534 —
Velocity Clinical Research, Westlake ( Site 3216) Los Angeles California 90057 —
Velocity Clinical Research, Panorama City ( Site 3214) Panorama City California 91402 —
California Liver Research Institute ( Site 3232) Pasadena California 91105 —
Clinical Trials Research ( Site 3230) Sacramento California 95821 —
Excel Medical Clinical Trials ( Site 3246) Boca Raton Florida 33434 —
Synergy Healthcare ( Site 3286) Bradenton Florida 34208 —
Synergy Healthcare LLC ( Site 3290) Brandon Florida 33511 —
Top Medical Research ( Site 3209) Cutler Bay Florida 33189 —
Covenant Metabolic Specialists, LLC ( Site 3231) Fort Myers Florida 33912 —
Velocity Clinical Research, Hallandale Beach ( Site 3241) Hallandale Florida 33009 —
Indago Research & Health Center, Inc ( Site 3207) Hialeah Florida 33012 —
Sweet Hope Research Specialty, Inc-Research ( Site 3200) Hialeah Florida 33016 —
Florida Research Institute ( Site 3243) Lakewood Rch Florida 34211 —
Genoma Research Group ( Site 3242) Miami Florida 33173 —
Floridian Clinical Research, LLC ( Site 3203) Miami Lakes Florida 33016-1518 —
Southeast Clinical Research Center ( Site 3288) Dalton Georgia 30720 —
Eagle Clinical Research ( Site 3233) Chicago Illinois 60621 —
University of Iowa ( Site 3213) Iowa City Iowa 52242 —
Kansas City Research Institute ( Site 3249) Kansas City Missouri 64131 —
The Machuca Foundation ( Site 3234) Las Vegas Nevada 89101 —
Velocity Clinical Research, Syracuse ( Site 3227) East Syracuse New York 13057 —
New York Gastroenterology Associates ( Site 3252) New York New York 10075 —
Velocity Clinical Research, Cincinnati ( Site 3237) Cincinnati Ohio 45242 —
Velocity Clinical Research, Providence ( Site 3222) East Greenwich Rhode Island 02818 —
Velocity Clinical Research, Austin ( Site 3235) Austin Texas 78759 —
South Texas Research Institute - Brownsville ( Site 3285) Brownsville Texas 78520 —
Velocity Clinical Research, Dallas ( Site 3220) Dallas Texas 75230 —
Houston Research Institute ( Site 3262) Houston Texas 77079 —
American Research Corporation ( Site 3202) San Antonio Texas 78215 —
Pinnacle Clinical Research ( Site 3284) San Antonio Texas 78229 —
Velocity Clinical Research, Salt Lake City ( Site 3223) West Jordan Utah 84088 —
Gastroenterology Consultants of Southwest Virginia ( Site 3282) Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05877547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05877547 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →